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The interferon-induced protein kinase PKR is activated upon binding double-stranded RNA and phosphorylates the
translation initiation factor eIF2a on Ser-51 to inhibit protein synthesis in virally infected cells. Swinepox virus C8L and
vaccinia virus K3L gene products structurally resemble the amino-terminal third of eIF2a. We demonstrate that the C8L
protein, like the K3L protein, can reverse the toxic effects caused by high level expression of human PKR in yeast cells. In
addition, expression of either the K3L or C8L gene product was found to reverse the inhibition of reporter gene translation
caused by PKR expression in mammalian cells. The inhibitory function of the K3L and C8L gene products in these assays was
found to be critically dependent on residues near the carboxyl-termini of the proteins including a sequence motif shared
among eIF2a and the C8L and K3L gene products. Thus, despite significant sequence differences both the C8L and K3L
proteins function as pseudosubstrate inhibitors of PKR. © 2000 Academic PressINTRODUCTION
One component in the cellular anti-viral defense
mechanism is the interferon-induced double-stranded
RNA (dsRNA)-activated protein kinase PKR. This protein
kinase specifically phosphorylates Ser-51 on the a sub-
nit of the translation initiation factor eIF2 (reviewed in
lemens, 1996). The eIF2 is a GTP-binding protein that in
he active GTP-bound state binds initiator methionyl-
RNA to form a ternary complex (reviewed in Trachsel,
996). The ternary complex can then bind to a 40S ribo-
omal subunit. The resulting 43S preinitiation complex
ubsequently binds to an mRNA and scans to the AUG
tart codon. To enable the 60S ribosomal subunit to join
nd translation elongation to proceed, the GTP of the
IF2 ternary complex is hydrolyzed to GDP and eIF2 is
eleased in a binary complex with GDP. The eIF2 protein
as a much higher affinity for GDP than for GTP, and a
econd factor, eIF2B, is required for guanine nucleotide
xchange on eIF2 to facilitate additional rounds of trans-
ation initiation. Phosphorylation of eIF2a on Ser-51 con-
verts eIF2 from a substrate into a competitive inhibitor of
eIF2B. Thus, phosphorylation of eIF2 results in inhibition
of eIF2B and a shut-off of cellular translation. It is thought
that dsRNAs generated from overlapping viral transcrip-
tion units or during viral replication activate PKR in virally
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424infected cells and thus trigger inhibition of host cell and
viral protein synthesis.
Viruses have developed a variety of strategies to over-
come the PKR component of the cellular anti-viral de-
fense mechanism (reviewed in Gale and Katze, 1998;
Katze, 1992). Adenoviruses express a small RNA termed
VAI that binds to PKR and prevents activation of the
kinase by dsRNA (Mathews, 1996). Influenza virus is
thought to activate a latent cellular inhibitor of PKR (Gale
et al., 1996), whereas the hepatitis C virus NS5A and E2
proteins have been reported to bind to PKR and block
PKR activity (Gale et al., 1997; Taylor et al., 1999). Vac-
cinia virus expresses two inhibitors of PKR. The E3L
gene product is a dsRNA binding protein that has been
thought to sequester the viral dsRNA activators of PKR
(Beattie et al., 1995; Chang, Watson, and Jacobs, 1992;
Davies et al., 1993; Jagus and Gray, 1994); however,
recent evidence suggests that the E3L protein may also
heterodimerize with PKR to block PKR function (Romano
et al., 1998; Sharp et al., 1998). The vaccinia virus K3L
gene product is a pseudosubstrate inhibitor of PKR
(Beattie, Tartaglia, and Paoletti, 1991; Carroll et al., 1993;
Davies et al., 1992; Kawagishi-Kobayashi et al., 1997).
The K3L protein resembles the N-terminal third of eIF2a
and the K3L protein will bind to PKR and block the kinase
activity. The greatest sequence similarity between eIF2a
and the K3L protein is found around 30 residues C-
terminal of the Ser-51 residue in eIF2a and near the
C-terminus of the K3L protein. Up to 10 out of 12 residues
in this sequence are perfectly identical among a variety
of eIF2a and K3L proteins from different organisms andiruses (see Fig. 1). The K3L protein has been shown to
ind to PKR (Carroll et al., 1993; Kawagishi-Kobayashi et
hs
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ally, can inhibit the other eIF2a kinases HRI (Carroll et al.,
1993) and GCN2 (Kawagishi-Kobayashi et al., 1997; Qian
et al., 1996). Finally, we previously showed that point
mutations that alter one of the residues conserved be-
tween the K3L protein and eIF2a block the ability of the
K3L protein to bind to PKR and inhibit PKR activity in
yeast cells (Kawagishi-Kobayashi et al., 1997).
The swinepox virus is a member of the poxvirus family
that specifically infects swine. Not only does the virus
have a limited host range, but the viral infection is rather
mild when compared to other members of the poxvirus
family. Whereas the entire genome sequence is known
for vaccinia virus (Goebel et al., 1990), only limited se-
quence information is available for swinepox virus. Com-
parison of the sequences of vaccinia and swinepox vi-
ruses revealed that the three proteins encoded on the
sequenced portion of the HindIII H fragment of swinepox
virus show very high amino acid sequence identities to
proteins encoded on the HindIII D fragment of vaccinia
virus (Massung, Jayarama, and Moyer, 1993). This simi-
larity has contributed to the idea that all vertebrate pox-
virus genomes share a conserved central core. However,
sequence data from the ends of the vaccinia and swine-
pox viral genomes identified both shared and unique
gene products in the two viruses (Massung, Jayarama,
and Moyer, 1993). In addition, the amino acid sequence
identity of the conserved proteins in these distal regions
is significantly less than for the proteins encoded in the
central region of the viral genomes. Many of the proteins
encoded near the termini of vaccinia virus genome are
thought to play roles in host range and defense against
host immune responses. Thus, the differences between
FIG. 1. Sequence similarity among the eIF2a and viral K3L protein
omologs. A partial amino acid sequence of human eIF2a (residues 1
and Hershey, 1987]), and full-length sequences of variola virus C3L prot
cowpox virus M3L protein (strain GRI-90; Y11842 [Shchelkunov et al., 19
winepox virus C8L protein (strain Kasza; L22013 [Massung, Jayaram
omputer Group, Inc.). The amino acid positions in each protein are ind
f the Ser-51 phosphorylation site in eIF2a, and the underlining indicate
residues are shaded, and the consensus sequence below the alignme
three different eIF2a proteins and five different viral K3L protein homovaccinia and swinepox viruses in these terminal regions
may be responsible for the limited host range and se-verity of swinepox virus infections. The C8L protein, en-
coded near the left end of the swinepox virus genome,
shows 43% amino acid sequence identity to the K3L
protein from vaccinia virus (Massung, Jayarama, and
Moyer, 1993). As the amino acid sequence of the K3L
protein homologs from variola virus (C3L protein) and
cowpox virus (M3L protein) are almost identical in se-
quence to the vaccinia virus K3L protein (see Fig. 1), and
all of these proteins are anticipated to be pseudosub-
strate inhibitors of PKR like the K3L protein, it is intriguing
that the amino acid sequence of the swinepox virus C8L
protein shows this marked divergence from the vaccinia
virus K3L protein sequence. To explore further the inhi-
bition of PKR by a pseudosubstrate and to increase our
understanding of the mechanism of substrate recogni-
tion by PKR, we decided to test the ability of the C8L
protein to function as a PKR inhibitor. Our results show
that the C8L protein can block PKR inhibition of transla-
tion in yeast and mammalian systems, and that the
inhibitory activities of both the K3L and C8L proteins are
dependent on the conserved sequence motifs located
near the C-termini of these proteins. These findings dem-
onstrate that the C8L protein is a pseudosubstrate inhib-
itor of PKR.
RESULTS
Swinepox virus C8L protein is a pseudosubstrate
inhibitor of PKR
Comparison of the amino acid sequence of the vac-
cinia virus K3L protein to proteins produced by other
poxviruses revealed that the variola virus C3L protein
and the cowpox virus M3L protein were practically iden-
logs. Alignment of amino acid sequences of eIF2a and K3L protein
of 315 residues total; GenBank accession no. J02645 [Ernst, Duncan,
ain India-1967; X69198 [Shchelkunov, Blinov, and Sandakhchiev, 1993]),
ccinia virus K3L protein (strain WR; D00382 [Boursnell et al., 1988]) and
d Moyer, 1993]) were aligned using the program PILEUP (Genetics
to the right of each line of sequence. The arrow indicates the position
ues that were mutated in the studies described in this report. Identical
cates residues that are perfectly conserved among the sequences of
awagishi-Kobayashi et al., 1997).homo
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sequence of the swinepox virus C8L protein shows only
v
s
t
t
y
K
o
3
E
p
p
l
p
i
p
a
t
c
1
r
t
(
w
m
w
K
3
t
a
K
K
o
i
t
t
t
t
t
r
w
p
C
B
P
c
T
h
426 KAWAGISHI-KOBAYASHI ET AL.43% identity and 67% similarity to the sequence of the
K3L protein (Fig. 1). However, the C8L protein sequence
does contain the sequence motif KGYID that is con-
served in eIF2a and was shown to be critical for inhibi-
tion of PKR by the K3L protein (Kawagishi-Kobayashi et
al., 1997). As a first step in examining the PKR inhibitory
activity of the swinepox virus C8L protein, we tested
whether the C8L protein could interact with PKR. The K3L
protein was previously shown to interact with PKR in the
yeast two-hybrid system (Cosentino et al., 1995; Craig et
al., 1996; Gale et al., 1996; Kawagishi-Kobayashi et al.,
1997; Sharp, Witzel, and Jagus, 1997). In this assay the
ability of various GAL4 DNA binding domain (BD) protein
fusions to interact with the GAL4 activation domain (AD)
fused to PKR was assessed by monitoring the ability of
pairs of these protein fusions to stimulate expression
from a GAL1-HIS3 reporter in vivo. A positive interaction
between the BD and AD fusion proteins can be assessed
in the yeast strain Y190 as conferring resistance to the
histidine analog 3-aminotriazole (3-AT). As shown previ-
ously (Kawagishi-Kobayashi et al., 1997), BD fusions with
either the K3L protein or the hyperactive K3L-H47R pro-
tein were capable of interacting with an AD-PKR-K296R
fusion to confer a 3-AT-resistant phenotype (Fig. 2A,
upper panel). When a BD-C8L fusion was tested in this
same assay it was likewise found to interact with BD-
PKR-K296R (Fig. 2A, upper and lower panels). When
tested with an AD vector lacking PKR sequences none of
the BD-K3L or BD-C8L protein fusions conferred 3-AT-
resistance (Fig. 2A, upper panel). Mutation of Tyr-80 to
Ala in the conserved KGYID motif of the C8L protein
abolished the interaction with PKR in the two-hybrid
assay (Fig. 2A, lower panel), as we previously observed
for the corresponding mutation in the K3L protein
(Kawagishi-Kobayashi et al., 1997).
To confirm the results of the yeast two-hybrid assays,
in vitro binding assays were used to test the interaction
between PKR and the C8L protein. Recombinant GST or
GST fused to the PKR kinase domain (GST-PKR, residues
258–551 of human PKR) were purified from E. coli and
incubated with whole cell extracts from yeast expressing
an N-terminal, HA-epitope-tagged version of the C8L
protein. As shown in Fig. 2B, the GST-PKR fusion, but not
GST alone, bound the HA-C8L protein (compare lane 6 to
lane 4). The low level of binding observed in these
experiments is consistent with previous reports on the
binding of the K3L protein to PKR (Carroll et al., 1993;
Kawagishi-Kobayashi et al., 1997). These results demon-
strate that the C8L protein can interact with PKR and are
consistent with the idea that the C8L protein is a
pseudosubstrate inhibitor of PKR.
To test if the swinepox virus C8L protein can inhibit
PKR function, we examined the effects of co-expressing
C8L with PKR in yeast cells. High level expression of
human PKR is toxic to yeast cells due to high-level
phosphorylation of eIF2a on Ser-51 and the resultantinhibition of translation initiation (Chong et al., 1992;
Dever et al., 1993). For these experiments, PKR was
expressed in yeast under the control of a galactose-
inducible GAL-CYC1 hybrid promoter in the expression
ector pEMBLyex4. Previously, we showed that expres-
ion of the vaccinia virus K3L protein under the control of
he same GAL-CYC1 hybrid promoter could suppress the
oxicity associated with high-level expression of PKR in
east (Kawagishi-Kobayashi et al., 1997). In addition, a
3L-H47R mutant protein was a more effective inhibitor
f PKR in yeast than was the wild-type K3L protein (Figs.
A and 3B, see also Kawagishi-Kobayashi et al., 1997).
xpression of swinepox virus C8L protein from the ex-
ression vector pEMBLyex4, like the vaccinia virus K3L
rotein, suppressed the toxicity associated with high-
evel expression of PKR in yeast (Figs. 3A and 3B). Com-
arison of colony size as a measure of cell growth,
ndicates that the C8L protein is as effective as the K3L
rotein for inhibiting PKR in yeast (Fig. 3B).
Based on sequence comparisons between the K3L
nd C8L proteins (Fig. 1), several mutant forms of these
wo proteins were generated. The C8L protein is trun-
ated at its C-terminus compared to the K3L protein (Fig.
), and we previously showed that the Lys-82 and Arg-83
esidues in the K3L protein, which are not conserved in
he C8L protein, are important for inhibition of PKR
Kawagishi-Kobayashi et al., 1997). When the K3L protein
as truncated by converting Arg-83 to a stop codon,
aking it comparable in length to the C8L protein, there
as a loss in activity, while the identically truncated
3L-H47R protein was still an effective PKR inhibitor (Fig.
A, see also Kawagishi-Kobayashi et al., 1997). However,
runcation of a single extra residue converting Lys-82 to
stop codon abolished the ability of both the K3L and
3L-H47R proteins to inhibit PKR in yeast (Kawagishi-
obayashi et al., 1997). The H47R mutation in K3L not
nly results in a more effective inhibitor of PKR, but
ncreases the similarity between the K3L and C8L pro-
eins (Fig. 1), as the native C8L protein contains Arg at
he corresponding position. We generated several mu-
ant forms of the C8L protein to assess the importance of
he residues corresponding to these critical residues in
he K3L protein. The C8L-R51H mutant protein alters the
esidue corresponding to His-47 in the K3L protein and
ould be predicted to reduce the activity of the C8L
rotein if this residue is performing a similar role in the
8L and K3L proteins. However, as shown in Fig. 3A and
, the C8L-R51H protein remains an effective inhibitor of
KR in yeast, indicating a possible difference in the
ontacts between PKR and the K3L and C8L proteins.
he K3L-Y76A mutation alters one of the residues in the
ighly conserved KGYID motif that is present in all eIF2a
and viral K3L protein homologs. This mutation not only
blocks the ability of the K3L protein to inhibit PKR in vivo,
but the mutant protein fails to bind to PKR in vitro and in
the yeast two-hybrid assay (Kawagishi-Kobayashi et al.,
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the AD-PKR-K296R plasmid and the BD-vector (pGBT9), the BD-spC8L
(pC910) or the BD-spC8L-Y80A (pC912) plasmids, as indicated. The
427SWINEPOX VIRUS C8L GENE PRODUCT INHIBITS PKR1997). As expected, the corresponding C8L-Y80A muta-
tion blocks the ability of the C8L protein to inhibit PKR in
yeast cells (Figs. 3A and 3B). These results are consis-
tent with the failure of the C8L-Y80A protein to interact
with PKR in the two-hybrid assay (Fig. 2A). Finally, to
assess the importance of the residues at the C-terminus
of the C8L protein we truncated the protein by either one
or four residues converting Val-86 or Val-83, respectively,
to a stop codon. While the C8L-V86* mutant protein
remained active, the C8L-V83* mutant protein was inac-
tive for inhibiting PKR in yeast cells (Fig. 3B, and data not
shown). These results demonstrate that the K3L and C8L
proteins have similar requirements for an intact KGYID
motif and C-terminal residues to function as PKR inhibi-
tors, and support the conclusion that, despite significant
sequence differences with the K3L protein, the C8L pro-
tein is a pseudosubstrate inhibitor of PKR.
To confirm these results and to examine protein ex-
pression levels, the C8L and C8L-Y80A proteins were
tagged at the N-terminus with the HA epitope. As shown
in Fig. 3C, the HA-spC8L protein remained a potent
inhibitor of PKR, and effectively restored growth in strains
containing two or one copies of the GAL-CYC1-PKR con-
struct. In addition, the HA-spC8L-Y80A, like the untagged
protein, remained inactive as a PKR inhibitor (Fig. 3C).
When whole-cell extracts from these transformants were
subjected to SDS-PAGE and immunoblot analysis using
anti-HA antibodies, it was found that the HA-spC8L and
HA-spC8L-Y80A proteins were expressed at similar lev-
els (Fig. 3D). Probing the immunoblot with anti-yeast
eIF2a antiserum confirmed that equivalent amounts of
total protein were analyzed for each strain (Fig. 3D, lower
panel). These results support the idea that the integrity of
the KGYID motif is critical for the inhibition of PKR by the
C8L protein.
Expression of swinepox C8L inhibits eIF2a
phosphorylation by PKR in yeast cells
To determine whether the inhibition of PKR toxicity in
yeast cells by the C8L protein was due to alterations in
transformants were streaked on SD medium supplemented with the
required nutrients plus 30 mM 3-aminotriazole and incubated at 30°C
for 7 days. The two-hybrid results presented in this figure are repre-
sentative of results obtained from at least three independent yeast
transformants. (B) GST-PKR binding assay. The indicated GST (lanes
3–4) or GST-PKR (lanes 5–6) fusions attached to glutathione-Sepharose
beads were incubated with whole cell extracts from yeast strain H1511
(Mata ura3–52 leu2–3 leu2–112 trp1-D63) expressing HA-tagged spC8L
(HA-C8L; pC919) under the control of a GAL-CYC1 promoter. The input
(I) lanes represent 10% (lane 1) and 5% (lane 2) of the yeast extracts
used for the binding assays. Following binding, the beads were pel-
leted and washed, and 5% of the supernatant (S) and 100% of the pellet
(P) fractions were analyzed by SDS-PAGE followed by immunoblottingFIG. 2. Yeast two-hybrid and protein binding analysis of the interac-
tion between PKR and the C8L and K3L proteins. (A) Yeast two-hybrid
assay. (Upper panel) Strain Y190 (Mata ade2–101 gal4-D gal80-D his3–
00 leu2–3 leu2–112 trp1-D901 ura3–52 LYS2::GAL1-HIS3
RA3::GAL1-lacZ, Harper et al., 1993) was co-transformed with plas-
ids encoding the GAL4 activation domain alone (AD-vector,
GAD424) or a fusion of this GAL4 domain to PKR-K296R (AD-PKR-
296R) and with plasmids encoding the GAL4 DNA binding domain
lone (BD-vector, pGBT9) or a fusion of this binding domain to full-
ength versions of wild-type K3L (BD-K3L, pC410), K3L-H47R (BD-K3L-
47R, pC411), or C8L (BD-spC8L, pC898) protein, as indicated. The
ransformants were streaked on minimal SD medium supplemented
ith the required nutrients plus 25 mM 3-aminotriazole and incubated
t 30°C for 3 days. (Lower panel) Strain Y190 was co-transformed withwith anti-GST antiserum (upper panel) and anti-HA monoclonal anti-
bodies (lower panel).
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GAL-CYC1-PKR construct integrated at the LEU2 locus. Patches of
transformants were grown to confluence on an SD plate and replica
a
428 KAWAGISHI-KOBAYASHI ET AL.eIF2a phosphorylation, we used isoelectric focusing
gels to monitor eIF2a phosphorylation. Results represen-
tative of at least two independent isoelectroic focusing
analyses are presented in Fig. 4. In yeast strains lacking
the endogenous eIF2a kinase GCN2 and expressing no
KR the eIF2a protein focused as a single form repre-
senting the basally phosphorylated protein (Fig. 4, lane 1,
see Dever et al., 1992). In yeast cells expressing wild-
type PKR, close to 50% of the eIF2a protein was found in
the form phosphorylated on Ser-51 (Fig. 4, lane 2). As
reported previously (Kawagishi-Kobayashi et al., 1997),
expression of wild-type K3L or the hyperactive K3L-H47R
resulted in modest or more significant, respectively, re-
ductions in the amount of eIF2a phosphorylated on
Ser-51 (Fig. 4, lanes 3 and 4). Expression of wild-type
swinepox C8L or the mutant C8L-R51H resulted in similar
reductions in the amount of eIF2a phosphorylated on
Ser-51 (Fig. 4, lanes 5 and 6), consistent with the ability
of these proteins to suppress PKR toxicity in yeast (Fig.
3A). Finally, expression of the swinepox C8L-V83* mutant
protein failed to reduce eIF2a phosphorylation (Fig. 4,
lane 7) consistent with the inability of this protein to
prevent PKR toxicity in yeast cells (Fig. 3B). The ability of
the C8L protein to reduce eIF2a phosphorylation by PKR
upports the conclusion that the C8L protein is a
seudosubstrate inhibitor of PKR.
printed to an SGal plate to induce K3L and PKR expression. The plate
was incubated at 30°C for 3 days. The hatched and darkly shaded
boxes in the cartoons represent the intact portions of the K3L and C8L
proteins, respectively; whereas the open boxes represent portions of
the proteins truncated by the introduction of stop codons. (B) Effects of
C8L point mutations on inhibition of PKR toxicity in yeast. Plasmids
expressing the indicated K3L and C8L proteins under the control of the
GAL-CYC1 hybrid promoter, or the vector pEMBLyex4 alone [vector
(1PKR)] were introduced into the yeast strain H2544 (Mata ura3–52
leu2–3 leu2–112 trp1-D63 ,GAL-CYC1-PKR, LEU2.1, Kawagishi-Koba-
yashi et al., 1997) containing one copy of a GAL-CYC1-PKR construct
integrated at the LEU2 locus. As a control the vector pEMBLyex4 was
introduced into the strain J110 (Mata ura3–52 leu2–3 leu2–112 trp1-D63
,LEU2., Kawagishi-Kobayashi et al., 1997) which lacks PKR [vector
(no PKR)]. The indicated transformants were streaked on minimal SGal
medium supplemented with only the required nutrients and incubated
at 30°C for 4 days. (C) Epitope-tagged alleles of spC8L are functional
in vivo. The plasmid pEMBLyex4 (vector) or pEMBLyex4 derivatives that
express HA-tagged spC8L (HA-spC8L; pC919) or spC8L-Y80A (HA-
spC8L-Y80A; pC921) were introduced into yeast strains H2543 (PKR2)
nd H2544 (PKR1), as indicated. Transformants were streaked on SGal
medium containing all amino acid supplements (but lacking uracil), and
then incubated at 30°C for 7 days. (D) Immunoblot analysis of C8L
protein levels in yeast. Twenty-two micrograms of total protein extracts
from the yeast strains in panel C, expressing HA-tagged C8L proteins,
were prepared as described previously (Kawagishi-Kobayashi et al.,
1997). Protein samples were analyzed by SDS-PAGE on a 4–20% gra-
dient gel followed by immunoblot analysis using anti-HA monoclonal
antibodies (12CA5) or polyclonal anti-yeast eIF2a antiserum, as indi-
cated. Immune complexes were visualized by enhanced chemilumi-
nescence (ECL). The various growth and protein expression data pre-FIG. 3. Coexpression of swinepox virus C8L suppresses the toxicity
f PKR expression in yeast. (A) Effects of point mutations in K3L and
8L on suppression of PKR toxicity in yeast. Plasmids expressing the
ndicated K3L and C8L alleles under the control of a yeast GAL-CYC1
promoter, or the vector pEMBLyex4 alone, were introduced into the
yeast strain H2543 (Mata ura3–52 leu2–3 leu2–112 trp1-D63 ,GAL-
CYC1-PKR, LEU2.2, Romano et al., 1995) containing two copies of asented in this figure are representative of results obtained from at least
2–3 independent transformants.
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429SWINEPOX VIRUS C8L GENE PRODUCT INHIBITS PKRThe results of this IEF analysis indicate that relatively
modest reductions in eIF2a phosphorylation can have
ramatic effects on the cellular growth rate. As the phos-
horylated form of eIF2 is a competitive inhibitor of its
uanine nucleotide exchange factor eIF2B and the levels
f eIF2 are thought to be roughly 10-fold higher than the
evels of eIF2B in the cell, it is commonly observed that
hosphorylation of a limited amount of eIF2 severely
ffects cellular translation rates. Previous studies in
east using constitutively activated alleles of the yeast
IF2 kinase GCN2 demonstrated a correlation between
ncreased levels of eIF2a phosphorylation and a slower
cellular growth rate (Ramirez et al., 1992). However,
these studies also demonstrated that modest increases
in eIF2a phosphorylation levels can have dramatic ef-
fects on the growth rates of cells (Ramirez et al., 1992).
Studies from both our lab (Dever et al., 1998; Kawagishi-
Kobayashi et al., 1997) and another lab (Gale et al., 1998)
using yeast strains expressing PKR or activated forms of
GCN2 have revealed that relatively small changes
(,10%) in the levels of eIF2a phosphorylation can sig-
ificantly affect yeast cell growth. Perhaps the translation
f a particular mRNA(s) that plays an important role in
egulating cellular growth rates is sensitive to small
hanges in eIF2 activity, as has been observed for the
CN4 mRNA in yeast (Hinnebusch, 1997). According to
his model, the modest reduction in eIF2a phosphoryla-
ion observed in cells co-expressing the C8L or K3L
rotein along with PKR, would increase eIF2 activity
bove a critical threshold required for efficient transla-
FIG. 4. Isoelectric focusing gel electrophoresis of eIF2a from yeast
trains producing various K3L, C8L, and PKR proteins. Plasmids ex-
ressing the indicated K3L or C8L alleles (lanes 3–7) or the empty
ector pEMBLyex4 (lane 2) were introduced into the yeast strain H2544
arrying one copy of the GAL-CYC1-PKR construct. As a control the
ector pEMBLyex4 was introduced into the strain J110 that lacks PKR
lane 1). Transformants were grown in minimal medium containing
alactose and raffinose to induce expression from the GAL promoter,
nd samples of whole cell extracts were separated by isoelectric
ocusing followed by immunoblot analysis with anti-yeast eIF2a anti-
serum, all as described previously (Kawagishi-Kobayashi et al., 1997).
Immune complexes were detected by ECL according to vendor’s in-
structions. As indicated, the form of eIF2a phosphorylated on Ser-51
focused above the basal species. The percentage of eIF2a that is
phosphorylated on Ser-51 was determined by quantitative densitometry
and is indicated below each lane.ion of a particular growth-promoting mRNA and thus
ead to a significant increase in the cellular growth rate.
d
(xpression of K3L or C8L reverses the translational
nhibition by PKR in mammalian cells
While the K3L and C8L proteins have been found to
unction as potent inhibitors of PKR in yeast cells, we
anted to test the effect of these proteins on PKR in a
ammalian cell system. Previous studies have demon-
trated that the K3L protein can reverse endogenous
KR inhibition of transgene expression (Davies et al.,
993; Davies et al., 1992). We chose to examine the
bility of wild-type and mutant forms of K3L to block the
bility of PKR to regulate reporter gene expression in a
ransient transfection assay. A luciferase reporter con-
truct was co-transfected into NIH-3T3 cells along with
arious K3L or C8L expression vectors in the presence or
bsence of a PKR expression plasmid. As a control we
lso examined the effects of co-transfecting the adeno-
irus VAI gene, which expresses VAI RNA, a known PKR
nhibitor (reviewed in Gale and Katze, 1998; Katze, 1992).
n the absence of the PKR expression vector, VAI, C8L
nd K3L-H47R increased translation of the luciferase
RNA when compared to the empty vector control (Fig.
A). Presumably these inhibitors are interfering with the
unction of the endogenous PKR expressed in NIH-3T3
ells, similar to what was observed previously (Davies et
l., 1993; Davies et al., 1992). In Fig. 5B high levels of
ufierase expression were obtained in the absence of an
nhibitor, and expression of the inhibitor did not further
nhance expression. We suspect that a higher transfec-
ion efficiency in the experiment presented in Fig. 5B
ersus Fig. 5A masked the effects associated with inhi-
ition of the endogenous PKR. In the presence of a
o-transfected PKR plasmid we found that luciferase
evels were significantly reduced in cells carrying an
mpty vector (Figs. 5A and 5B, bar labeled vector). Ex-
ression of adenovirus VAI RNA partially suppressed the
nhibition of luciferase expression by PKR (Fig. 5A);
hereas C8L, wild-type K3L, and K3L-H47R significantly
ncreased luciferase expression (Figs. 5A and 5B). In
ontrast, when K3L-Y76A was expressed in the presence
f PKR, luciferase levels were comparable to those ob-
ained in the absence of K3L (Fig. 5B). The results from
hese transfection experiments that include PKR are con-
istent with the results from the yeast experiments, and
ndicate that the K3L-H47R protein is a more effective
nhibitor of PKR, whereas the K3L-Y76A protein is unable
o inhibit PKR. Therefore, we conclude that the yeast
odel system is a valid tool to study PKR and the viral
egulators of PKR. To confirm that the changes in lucif-
rase levels were the result of translation differences
nd not due to effects on luciferase mRNA levels, RT-
CR was used to quantify luciferase mRNA levels from
ells expressing various combinations of PKR and inhib-
tors. As shown in Fig. 5C, luciferase mRNA was only
etected in cells transfected with the pGL3-Luc reporter
compare lanes 3–14 versus 1–2). In addition, the lucif-
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430 KAWAGISHI-KOBAYASHI ET AL.erase mRNA levels in cells expressing PKR (lane 4) or
PKR plus an inhibitor (lanes 6, 8, 10, 12, and 14) were
similar despite significant differences in luciferase levels
detected in these same transfectants (Figs. 5A and 5B).
Therefore, we conclude that the alterations in luciferase
activity detected in the cells expressing PKR and C8L,
FIG. 5. Analysis of PKR translational regulatory function in mamma-
lian cells coexpressing C8L, K3L or VAI gene products. (A and B)
NIH-3T3 cells (4 3 104 cells) were transiently cotransfected with three
lasmids: 1) 300 ng of the luciferase reporter construct pGL3-Control
ector (Promega); 2) 30 ng of either empty vector pC869 (open boxes)
r the PKR expression vector pC882 (filled boxes); and 3) 1.2 mg of
either empty vector pC869 or vector to express the indicated C8L or
K3L proteins or VAI RNA (see Materials and Methods). Luciferase
activity was determined for three independent transfections and the
average result and standard deviation are shown. (C) RT-PCR analysis
of luciferase mRNA levels. The amount of luciferase reporter and
b-actin mRNAs present in the indicated transfectants was determined
by RT-PCR, as described in Materials and Methods.K3L, or VAI were due to effects on luciferase mRNA
translation and not on transcription or mRNA stability.
bFinally, protein immunoblot analyses demonstrated that
expression of K3L-H47R, the most potent rescuer of
luciferase expression, did not reduce PKR levels in the
transfected cells (data not shown), indicating that the
increased luciferase expression was due to inhibition of
PKR activity.
DISCUSSION
In this report we have demonstrated that the swinepox
virus C8L protein is an inhibitor of the cellular anti-viral
kinase PKR. Like the vaccinia virus K3L protein, swine-
pox virus C8L protein blocked the translational inhibitory
activity of PKR in yeast cells. In addition, the PKR-inhib-
itory activity of the C8L protein was dependent on the
conserved KGYID motif found in eIF2a and the vaccinia
virus K3L homologs from a number of poxviruses. Finally,
we showed that the K3L and C8L proteins are also potent
inhibitors of PKR in mammalian cells. These results sup-
port the conclusion that the C8L and K3L proteins are
pseudosubstrate inhibitors of PKR, and these latter re-
sults validate the use of the yeast model system to study
viral regulators of PKR.
Despite the significant sequence differences among
the swinepox virus C8L protein and the vaccinia virus
K3L protein homologs of other poxviruses, the C8L pro-
tein is a potent inhibitor of PKR. Comparison of the
sequences of the K3L and C8L proteins to the sequence
of eIF2a may help identify the key sequence elements
used by PKR for recognition of its authentic substrate
eIF2a as well as the pseudosubstrate inhibitors. The
est conserved sequence element among eIF2a and the
3L and C8L proteins is the motif KGYID found near the
-termini of the pseudosubstrates (Fig. 1). As shown
reviously for the K3L protein (Kawagishi-Kobayashi et
l., 1997), and as shown in this report for the C8L protein,
ubstitution of Ala in place of the conserved Tyr residue
ithin the KGYID motif blocks the ability of the K3L and
8L proteins to inhibit PKR. In addition, this mutation
educes the binding of the C8L or K3L protein to PKR
Kawagishi-Kobayashi et al., 1997). Thus, it seems likely
hat PKR recognition of eIF2a is mediated at least in part
hrough interaction with the KGYID motif, as also sug-
ested by Sharp, Witzel, and Jagus (1997). Neither the
3L nor the C8L protein shows similarity to the se-
uences flanking the PKR phosphorylation site at Ser-51
n eIF2a (see Fig. 1), and the K3L and C8L protein
equences in the region corresponding to eIF2a Ser-51
differ as well. Therefore, we propose that substrate bind-
ing to PKR is not critically dependent on the residues
flanking the Ser-51 phosphorylation site. Our previous
mutational analysis of K3L suggested that the K3L pro-
tein sequence corresponding to the region around
Ser-51 in eIF2a was important for pseudosubstrate inhi-ition of PKR (Kawagishi-Kobayashi et al., 1997). Because
the C8L protein sequence in this region does not resem-
ic
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sequences in the C8L and K3L proteins, corresponding
to position-51 region in eIF2a, are compatible with PKR
nhibition.
Both the K3L and E3L gene products have been impli-
ated in the interferon-resistant phenotype of vaccinia
irus. Several studies have examined the role of the K3L
rotein and the relative contributions of the K3L and E3L
ene products to the interferon-resistance of vaccinia
irus (Beattie, Paoletti, and Tartaglia, 1995; Davies et al.,
993; Jagus and Gray, 1994). Vaccinia virus mutants lack-
ng the K3L gene show increased sensitivity to interferon
Beattie, Paoletti, and Tartaglia, 1995; Beattie, Tartaglia,
nd Paoletti, 1991) and expression of the K3L gene in
rans can stimulate translation of a reporter mRNA in
ammalian cells (Davies et al., 1993; Davies et al., 1992).
The E3L gene encodes a dsRNA binding protein that is
thought to inhibit PKR by sequestering dsRNA activators
and by forming inactive heterodimers with PKR (Chang,
Watson, and Jacobs, 1992; Davies et al., 1993; Jagus and
Gray, 1994; Romano et al., 1998; Sharp et al., 1998). The
PKR-inhibitory activity of the E3L protein could be re-
versed by addition of higher levels of dsRNA; however,
the inhibitory function of the K3L protein was insensitive
to dsRNA (Davies et al., 1993; Jagus and Gray, 1994).
Comparison of the expression pattern of the K3L and E3L
proteins revealed that K3L expression is limited to the
immediate-early and early times post-infection (i.e., 0 to
2 h post-infection), whereas the E3L protein can be
detected immediately post-infection and its expression
persists until at least 12 h post-infection (Beattie, Paoletti,
and Tartaglia, 1995; Watson, Chang, and Jacobs, 1991).
Consistent with this expression pattern the K3L protein
appeared to be critical immediately post-infection to
counteract the effects of interferon, while the E3L protein
was not important until around 2 h post-infection (Beattie,
Paoletti, and Tartaglia, 1995). A vaccinia virus E3L protein
homolog has not been reported for swinepox virus; how-
ever, this may simply reflect the limited sequence infor-
mation available for swinepox virus. Based on the DNA
sequence elements present both within and flanking the
C8L open reading frame in swinepox virus it was pre-
dicted that the C8L protein would be expressed at late
times post-infection (Massung, Jayarama, and Moyer,
1993). This predicted extended duration of swinepox
virus C8L expression compared to vaccinia virus K3L
expression may reflect a more extensive role for the C8L
protein in swinepox virus infections. As only a few stud-
ies have been reported on swinepox virus and the func-
tion of various proteins expressed from the virus, the
results in this report provide initial experimental evi-
dence as to how swinepox virus may counteract host cell
defense mechanisms.
A number of viral regulators of PKR have been identi-
fied (reviewed in Gale and Katze, 1998; Katze, 1992), and
the yeast model system described in this report hasbeen used to identify and characterize several of these
regulators. In addition to vaccinia virus K3L (Kawagishi-
Kobayashi et al., 1997), the vaccinia virus E3L protein
(Romano et al., 1998), the hepatitis C virus NS5A (Gale et
al., 1997) and E2 (Taylor et al., 1999) proteins, and the
cellular P58IPK protein, which blocks PKR activity in influ-
enza virus infected cells (Gale et al., 1998), have all been
shown to suppress PKR toxicity in yeast. This yeast
system was also instrumental in identifying the baculo-
virus PK2 protein, which resembles a truncated eIF2a
kinase domain, as a PKR inhibitor (Dever et al., 1998).
One of the common features of the viral inhibitors that
have been successfully analyzed in the yeast system,
including the C8L protein as demonstrated in this report,
is that they all have been shown to interact with PKR in
the yeast two-hybrid assay. Thus, we anticipate that this
yeast system should be useful in identifying and studying
new viral proteins that block PKR function by directly
interacting with the kinase.
MATERIALS AND METHODS
Plasmids
The plasmids to express K3L (pC140), K3L-H47R
(pC407), K3L-H47R-Y76A (pC340), K3L-R83* (pC381), K3L-
H47R-R83* (pC383), and K3L-H47R-K82* (pC384) in yeast
cells under the control of a GAL-CYC1 hybrid promoter
have been described previously (Kawagishi-Kobayashi et
al., 1997). To express swinepox C8L in yeast cells, DNA
encoding the C8L protein was amplified by PCR using
swinepox virus DNA (strain Kasza, a gift of Drs. Richard
Moyer and Peter Turner, University of Florida, Gaines-
ville) as the template and primers that introduce an NcoI
restriction enzyme site at the AUG codon (this results in
changing the second C8L amino acid from Ser to Ala)
and an XbaI site at the 39 end of the open reading frame.
The PCR product was digested with NcoI and XbaI and
hen ligated to the plasmid pC312 (Kawagishi-Kobayashi
t al., 1997) that had been digested with the same en-
ymes to generate the plasmid pC884. A SacI-XbaI frag-
ent from pC884 containing the C8L open reading frame
as inserted between the same sites of the yeast ex-
ression vector pEMBLyex4 (Cesareni and Murray, 1987)
o generate the plasmid pC879. The C8L-R51H allele was
enerated by PCR using a 59 primer that maintained the
acI site and a 39 primer containing a BglII site that
ntroduced the R51H mutation (59-AGA-39 to 59-CAT-39).
he PCR product was digested with SacI and BglII and
nserted between the same sites of pC884 to generate
C892. The C8L-Y80A and C8L-V83* alleles were gener-
ted by PCR using the same 59 primer containing the
acI site and 39 primers containing a MunI site to intro-
duce the Y80A (59-TAT-39 to 59-GCT-39) or the V83* (59-
GTT-39 to 59-TAA-39) mutations. The PCR products were
digested with SacI and MunI and inserted between the
same sites of pC884 to generate the plasmids pC893
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Y80A, and C8L-V83* alleles in the plasmids pC892-
pC894 were then transferred to the vector pEMBLyex4
on SacI-XbaI fragments to generate the plasmids pC895-
pC897, respectively. Epitope-tagged alleles of C8L were
generated by PCR in two steps. First, DNA encoding the
hemagglutinin (HA) epitope was amplified using a set of
primers that introduced a 59 SacI site and introduced C8L
sequences at the 39 end of the PCR product. The product
of this first PCR was used as a 59 primer in a second PCR
that included 39 primers containing a BamHI site that
were specific for wild-type C8L or C8L-Y80A. The prod-
ucts of this second PCR were digested with SacI and
BamHI and inserted between the same sites of
pEMBLyex4 to generate the plasmids pC919 (HA-spC8L)
and p921 (HA-spC8L-Y80A).
The plasmid pAD-PKR-K296R was obtained from Drs.
Michael Gale and Michael Katze (University of Washing-
ton, Seattle). The construction of the plasmids to express
BD-K3L (pC410) and BD-K3L-H47R (pC411) was de-
scribed previously (Kawagishi-Kobayashi et al., 1997).
Primers that introduce a 59 EcoRI site and a 39 BamHI
site were used to amplify the C8L and C8L-Y80A open
reading frames using PCR. The resulting products were
cloned between the EcoRI and BamHI sites of the vector
pGBT9 (Clontech) to generate the GAL4 DNA binding
domain-C8L (BD-spC8L) expression plasmids pC898
and pC910 and the BD-spC8L-Y80A expression plasmid
pC912. The GST-PKR expression vector pC676 was con-
structed in three steps. First, a BstZ17I-HindIII fragment
encoding the PKR kinase domain residues 258–551 was
isolated from the plasmid p1419 (Dever et al., 1993) and
inserted between the SmaI and HindIII sites of the plas-
mid pEGKT (Mitchell, Marshall, and Deschenes, 1993)
creating the plasmid pC661. Next, the PKR fragment was
excised from pC661 as a BamHI-HindIII fragment and
inserted between the same sites of pRS316 (Sikorski and
Hieter, 1989) generating the plasmid pC675. Finally, a
BamHI-XhoI fragment containing the PKR sequences
was isolated from pC675 and inserted between the same
sites of the vector pGEX-4T-2 (Amersham Pharmacia
Biotech) to create pC676.
Plasmids for expression of PKR, K3L, and C8L alleles
in mammalian cells were derived from the expression
vector pSG5 (Stratagene). First, the polylinker of the vec-
tor pSG5 was modified to include the sites EcoRI-SacI-
KpnI-BamHI-PstI-HindIII-XhoI-BglII to generate the plas-
mid pC869. A KpnI-HindIII DNA fragment encoding PKR
was isolated from the plasmid p1419 (Dever et al., 1993)
and inserted between the same sites of pC869 generat-
ing the plasmid pC882. Using PCR with primers de-
signed to introduce a 59 SacI site and a 39 BamHI site the
K3L (pC872), K3L-H47R (pC887), K3L-Y76A (pC888) and
C8L (pC889) alleles were amplified and then inserted
between the same sites of the plasmid pC869.
5
aProtein binding assay
The GST-PKR fusion protein was overexpressed in E.
coli strain DH5a carrying the plasmid pC676, and puri-
fied by affinity chromatography using glutathione-Sepha-
rose (Amersham Pharmacia Biotech). The GST-PKR was
eluted in 50 mM Tris-HCl, pH 8.0 containing 10 mM
glutathione, and then dialyzed against 1x PBS. A GST
control protein, encoded on the plasmid pGEX-4T-2, was
overexpressed and purified in the same manner. The
yeast strain H1511 (Foiani et al., 1991) carrying the
plasmid pC919 was grown in medium containing 2%
galactose plus 2% raffinose as described previously
(Kawagishi-Kobayashi et al., 1997), and whole cell ex-
tracts were prepared as described elsewhere (Drysdale
et al., 1998). Twenty micrograms of purified GST or GST-
PKR was mixed with 53 binding buffer containing pro-
tease inhibitors (Drysdale et al., 1998), 1.05 mg of whole
yeast cell extract, and water to a final volume of 100 ml.
The binding reactions were mixed well and incubated on
ice for 1 h. Glutathione-Sepharose resin was washed in
1.53 binding buffer, and then 20 ml aliquots were added
to each binding reaction. The binding reactions were
then gently mixed at 4°C for 2 h, and the resin was
collected and washed as described previously (Drysdale
et al., 1998). The final pellets were suspended in 25 ml
2.53 SDS sample buffer, boiled for 5 min, and fraction-
ated by 4–20% SDS-PAGE. The resolved proteins were
analyzed by immunoblotting using anti-HA monoclonal
antibodies 12CA5 (Roche) and polyclonal anti-GST anti-
serum (Santa Cruz Biotechnology).
Transfection experiments and RT-PCR
NIH-3T3 cells were grown in Dulbecco’s modified Ea-
gle’s medium supplemented with 10% FBS. For transient
transfections, NIH-3T3 cells (4 3 104 cells per well in a
24-well plate) were seeded the day before transfection.
Cells were incubated with a mixture of DNA and the
lipofectamine reagents (Life Technologies, Inc.) for 6 h.
The DNA mixture contained the firefly luciferase reporter
plasmid pGL3-Control Vector (Promega) (300 ng), PKR
(pC882; 30 ng), and K3L (pC872; 1.2 mg) or C8L (pC889;
1.2 mg) expression plasmids, or empty vectors (pC869;
1.2 mg). Cells were fed with medium containing serum
and incubated for 24 h. The cells were lysed in 100 ml
lysis buffer (PharMingen International) and 35 ml aliquots
were assayed for luciferase activity. For RT-PCR, total
RNA was extracted from transfected cells using RNAzol
B (TEL-TEST, Inc). Starting with 2.5 mg of total RNA for
ach sample, first strand cDNA was synthesized using
andom primers and SUPERSCRIPT II (Gibco). A portion
f the cDNA was then amplified using a set of luciferase
r b-actin specific primers for 30 (luciferase) or 25
(b-actin) cycles of the following steps: 95°C for 30 s,
2°C for 45 s, and 72°C for 50 s. The PCR products were
nalyzed by electrophoresis on a 2% agarose gel which
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bands.
ACKNOWLEDGMENTS
We thank I-Ming Wang, Shigekazu Sasaki, and Atsuko Masumi for
assistance with the initial mammalian cell culture experiments; Richard
Moyer and Pete Turner for the swinepox virus DNA; Alan Hinnebusch
for comments on the manuscript; and members of the Dever, Ozato,
and Hinnebusch laboratories for helpful discussions.
REFERENCES
Beattie, E., Denzler, K. L., Tartaglia, J., Perkus, M. E., Paoletti, E., and
Jacobs, B. L. (1995). Reversal of the interferon-sensitive phenotype of
a vaccinia virus lacking E3L by expression of the reovirus S4 gene.
J. Virol. 69, 499–505.
eattie, E., Paoletti, E., and Tartaglia, J. (1995). Distinct patterns of IFN
sensitivity observed in cells infected with vaccinia K3L2 and E3L2
mutant viruses. Virology 210, 254–263.
Beattie, E., Tartaglia, J., and Paoletti, E. (1991). Vaccinia virus-encoded
eIF-2a homolog abrogates the antiviral effect of interferon. Virology
183, 419–422.
oursnell, M. E., Foulds, I. J., Campbell, J. I., and Binns, M. M. (1988).
Non-essential genes in the vaccinia virus HindIII K fragment: A gene
related to serine protease inhibitors and a gene related to the 37K
vaccinia virus major envelop antigen. J. Gen. Virol. 69, 2995–3003.
arroll, K., Elroy-Stein, O., Moss, B., and Jagus, R. (1993). Recombinant
vaccinia virus K3L gene product prevents activation of double-
stranded RNA-dependent, initiation factor 2a-specific protein kinase.
J. Biol. Chem. 268, 12837–12842.
Cesareni, G., and Murray, J. A. H. (1987). Plasmid vectors carrying the
replication origin of filamentous single-stranded phages. In “Genetic
Engineering: Principals and Methods” (J. K. Setlow and A. Hol-
laender, Eds.), Vol. 9, pp. 135–154. Plenum Press, New York.
Chang, H. W., Watson, J. C., and Jacobs, B. L. (1992). The E3L gene of
vaccinia virus encodes an inhibitor of the interferon-induced, double-
stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA
89, 4825–4829.
hong, K. L., Feng, L., Schappert, K., Meurs, E., Donahue, T. F., Friesen,
J. D., Hovanessian, A. G., and Williams, B. R. G. (1992). Human p68
kinase exhibits growth suppression in yeast and homology to the
translational regulator GCN2. EMBO J. 11, 1553–1562.
lemens, M. J. (1996). Protein kinases that phosphorylate eIF2 and
eIF2B, and their role in eukaryotic cell translational control. In “Trans-
lational Control” (J. W. B. Hershey, M. B. Mathews, and N. Sonenberg,
Eds.), pp. 139–172. Cold Spring Harbor Laboratory Press, Plainview,
NY.
osentino, G. P., Venkatesan, S., Serluca, F. C., Green, S. R., Mathews,
M. B., and Sonenberg, N. (1995). Double-stranded-RNA-dependent
protein kinase and TAR RNA-binding protein form homo- and het-
erodimers in vivo. Proc. Natl. Acad. Sci. USA 92, 9445–9449.
Craig, A. W. B., Cosentino, G. P., Donze, O., and Sonenberg, N. (1996).
The kinase insert domain of interferon-induced protein kinase PKR is
required for activity but not for interaction with the pseudosubstrate
K3L. J. Biol. Chem. 271, 24526–24533.
Davies, M. V., Chang, H. W., Jacobs, B. L., and Kaufman, R. J. (1993). The
E3L and K3L vaccinia virus gene products stimulate translation
through inhibition of the double-stranded RNA-dependent protein
kinase by different mechanisms. J. Virol. 67, 1688–1692.
Davies, M. V., Elroy-Stein, O., Jagus, R., Moss, B., and Kaufman, R. J.
(1992). The vaccinia virus K3L gene product potentiates translation
by inhibiting double-stranded-RNA-activated protein kinase and
phosphorylation of the alpha subunit of eukaryotic initiation factor 2.
J. Virol. 66, 1943–1950.
Dever, T. E., Chen, J. J., Barber, G. N., Cigan, A. M., Feng, L., Donahue,
MT. F., London, I. M., Katze, M. G., and Hinnebusch, A. G. (1993).
Mammalian eukaryotic initiation factor 2a kinases functionally sub-
stitute for GCN2 in the GCN4 translational control mechanism of
yeast. Proc. Natl. Acad. Sci. USA 90, 4616–4620.
Dever, T. E., Feng, L., Wek, R. C., Cigan, A. M., Donahue, T. D., and
Hinnebusch, A. G. (1992). Phosphorylation of initiation factor 2a by
protein kinase GCN2 mediates gene-specific translational control of
GCN4 in yeast. Cell 68, 585–596.
Dever, T. E., Sripriya, R., McLachlin, J. R., Lu, J., Fabian, J. R., Kimball,
S. R., and Miller, L. K. (1998). Disruption of cellular translational
control by a viral truncated eukaryotic translation initiation factor 2a
kinase homolog. Proc. Natl. Acad. Sci. USA 95, 4164–4169.
Drysdale, C. M., Jackson, B. M., McVeigh, R., Klebanow, E. R., Bai, Y.,
Kokubo, T., Swanson, M., Nakatani, Y., Weil, P. A., and Hinnebusch,
A. G. (1998). The Gcn4p activation domain interacts specifically in
vitro with RNA polymerase II holoenzyme, TFIID, and the Adap-
Gcn5p coactivator complex. Mol. Cell. Biol. 18, 1711–1724.
Ernst, H., Duncan, R. F., and Hershey, J. W. B. (1987). Cloning and
sequencing of complementary DNAs encoding the a-subunit of
translational initiation factor eIF-2. J. Biol. Chem. 262, 1206–1212.
Foiani, M., Cigan, A. M., Paddon, C. J., Harashima, S., and Hinnebusch,
A. G. (1991). GCD2, a translational repressor of the GCN4 gene, has
a general function in the initiation of protein synthesis in Saccharo-
myces cerevisiae. Mol. Cell. Biol. 11, 3203–3216.
Gale, M., Blakely, C. M., Hopkins, D. A., Melville, M. W., Wambach, M.,
Romano, P. R., and Katze, M. G. (1998). Regulation of interferon-
induced protein kinase PKR: Modulation of P58rIPK inhibitory function
by a novel protein, P52rIPK. Mol. Cell. Biol. 18, 859–871.
ale, M., Jr., and Katze, M. G. (1998). Molecular mechanisms of inter-
feron resistance mediated by viral-directed inhibition of PKR, the
interferon-induced protein kinase. Pharmacol. Ther. 78, 29–46.
Gale, M., Tan, S.-L., Wambach, M., and Katze, M. G. (1996). Interaction
of the interferon-induced PKR protein kinase with inhibitory proteins
P58IPK and vaccinia virus K3L is mediated by unique domains: Impli-
cations for kinase regulation. Mol. Cell. Biol. 16, 4172–4181.
Gale, M. J., Jr., Korth, M. J., Tang, N. M., Tan, S.-L., Hopkins, D. A., Dever,
T. E., Polyak, S. J., Gretch, D. R., and Katze, M. G. (1997). Evidence that
hepatitis C virus resistance to interferon is mediated through repres-
sion of the PKR protein kinase by the nonstructural 5A protein.
Virology 230, 217–227.
Goebel, S. J., Johnson, G. P., Perkus, M. E., Savis, S. W., Winslow, J. P.,
and Paoletti, E. (1990). The complete DNA sequence of vaccinia
virus. Virology 179, 247–266, 517–563.
Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J.
(1993). The p21 Cdk-interacting protein Cip1 is a potent inhibitor of
G1 Cyclin-dependent kinases. Cell 75, 805–816.
Hinnebusch, A. G. (1997). Translational regulation of yeast GCN4: A
window on factors that control initiator-tRNA binding to the ribosome.
J. Biol. Chem. 272, 21661–21664.
Jagus, R., and Gray, M. M. (1994). Proteins that interact with PKR.
Biochimie (Paris) 76, 779–791.
Katze, M. G. (1992). The war against the interferon-induced dsRNA-
activated protein kinase: Can viruses win? J. Interferon Res. 12,
241–248.
Kawagishi-Kobayashi, M., Silverman, J. B., Ung, T. L., and Dever, T. E.
(1997). Regulation of the protein kinase PKR by the vaccinia virus
pseudosubstrate inhibitor K3L is dependent on residues conserved
between the K3L protein and the PKR substrate eIF2a. Mol. Cell. Biol.
17, 4146–4158.
assung, R. F., Jayarama, V., and Moyer, R. W. (1993). DNA sequence
analysis of conserved and unique regions of swinepox virus: Iden-
tification of genetic elements supporting phenotypic observations
including a novel G protein-coupled receptor homologue. Virology
197, 511–528.
athews, M. B. (1996). Interactions between viruses and the cellular
machinery for protein synthesis. In “Translational Control” (J. W. B.
434 KAWAGISHI-KOBAYASHI ET AL.Hershey, M. B. Mathews, and N. Sonenberg, Eds.), pp. 505–548. Cold
Spring Harbor Laboratory Press, Plainview, NY.
Mitchell, D. A., Marshall, T. K., and Deschenes, R. J. (1993). Vectors for
the inducible overexpression of glutathione S-transferase fusion pro-
teins in yeast. Yeast 9, 715–722.
Qian, W., Zhu, S., Sobolev, A. Y., and Wek, R. C. (1996). Expression of
vaccinia virus K3L protein in yeast inhibits eukaryotic initiation fac-
tor-2 kinase GCN2 and the general amino acid control pathway.
J. Biol. Chem. 271, 13202–13207.
Ramirez, M., Wek, R. C., Vazquez de Aldana, C. R., Jackson, B. M.,
Freeman, B., and Hinnebusch, A. G. (1992). Mutations activating the
yeast eIF-2a kinase GCN2: Isolation of alleles altering the domain
related to histidyl-tRNA synthetases. Mol. Cell. Biol. 12, 5801–5815.
Romano, P. R., Green, S. R., Barber, G. N., Mathews, M. B., and Hinne-
busch, A. G. (1995). Structural requirements for double-stranded RNA
binding, dimerization, and activation of the human eIF-2a kinase DAI
in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 365–378.
Romano, P. R., Zhang, F., Tan, S. L., Garcia-Barrio, M. T., Katze, M. G.,
Dever, T. E., and Hinnebusch, A. G. (1998). Inhibition of double-
stranded RNA-dependent protein kinase PKR by vaccinia virus E3:
Role of complex formation and the E3 N-terminal domain. Mol. Cell.
Biol. 18, 7304–7316.
Sharp, T. V., Romashko, A., Moonan, F., Joshi, B., Barber, G. N., and
Jagus, R. (1998). The vaccinia virus E3L gene product interacts with
both the regulatory and substrate binding regions of PKR: Implica-
tions for PKR autoregulation. Virology 250, 302–315.Sharp, T. V., Witzel, J. E., and Jagus, R. (1997). Homologous regions of
the alpha subunit of eukaryotic translational initiation factor 2
(eIF2alpha) and the vaccinia virus K3L gene product interact with
same domain within the dsRNA-activated protein kinase (PKR). Eur.
J. Biochem. 250, 85–91.
Shchelkunov, S. N., Blinov, V. M., and Sandakhchiev, L. S. (1993). Genes
of variola and vaccinia viruses necessary to overcome the host
protective mechanisms. FEBS Lett. 319, 80–83.
Shchelkunov, S. N., Safronov, P. F., Totmenin, A. V., Petrov, N. A.,
Ryazankina, O. I., Gutorov, V. V., and Kotawl, G. J. (1998). Species-
specific differences in genome organization of cowpox, smallpox,
and vaccinia viruses. Virology 243, 432–460.
Sikorski, R. S., and Hieter, P. (1989). A system of shuttle vectors and
yeast host strains designed for efficient manipulation of DNA in
Saccharomyces cerevisiae. Genetics 122, 19–27.
Taylor, D. R., Shi, S. T., Romano, P. R., Barber, G. N., and Lai, M. M. C.
(1999). Inhibition of the interferon-inducible protein kinase PKR by
HCV E2 protein. Science 285, 107–110.
Trachsel, H. (1996). Binding of initiator methionyl-tRNA to ribosomes. In
“Translational control” (J. W. B. Hershey, M. B. Mathews, and N.
Sonenberg, Eds.), pp. 113–138. Cold Spring Harbor Laboratory Press,
Plainview.
Watson, J. C., Chang, H. W., and Jacobs, B. L. (1991). Characterization of
a vaccinia virus-encoded double-stranded RNA-binding protein that
may be involved in inhibition of the double-stranded RNA-dependent
protein kinase. Virology 185, 206–216.
